Re:Biohackers take aim at big pharma’s stranglehold on insulin
by lotsofpulp on Monday June 28, 2021 @02:57PM
(#27666141)
I am not addressing it, because I do not see any further evidence of distortion of an MCO's net profit margin other than what this article claims. Nor would it matter to me unless some MCO executives are smuggling cash out of the country or something.
As a customer, it does not affect me.
In the healthcare business, the flow of money is:
Individual -> MCO (insurance company) -> healthcare providers and drug manufacturers
What does it matter to the individual what portion of an MCO is earning what profit if the net profit margin of the whole MCO is 5% or less? They are obviously not left with a lot of money, their employees are not known to be lavishly compensated.
As a customer, it does not affect me.
In the healthcare business, the flow of money is:
Individual -> MCO (insurance company) -> healthcare providers and drug manufacturers
What does it matter to the individual what portion of an MCO is earning what profit if the net profit margin of the whole MCO is 5% or less? They are obviously not left with a lot of money, their employees are not known to be lavishly compensated.